The market is pricing NEGG like a distressed asset, and frankly the income statement justifies that skepticism. With no trailing or forward P/E, negative EPS of -62.8, and EPS next year estimated at -$1.18, this is not a growth compounding story but a restructuring or survival story. Operating margin sits at -19.80% and ROIC at -11.40%, meaning capital is actively being destroyed. However, the Altman Z-Score of 4.5 signals low near-term bankruptcy risk, and a Piotroski F-Score of 7 suggests improving internal fundamentals despite losses. At 0.5x sales and a $764M market cap, the stock trades at a depressed revenue multiple, but without profitability or visible forward earnings, the valuation discount is a reflection of operational fragility rather than clear mispricing.